Found 184 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia PHASE2 This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease PHASE1 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma NA The clinical trial was designed as a single-arm, open-label clinical study,...
Show More Location
The Second Affiliated Hospital of Soochow University
Learn More & Join Trial
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases EARLY_PHASE1 This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Learn More & Join Trial
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma PHASE3 The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT PHASE2 This is a prospective study comparing autologous hematopoietic stem cell tr...
Show More Location
The Affiliated Hospital oh Xuzhou Medical University
Learn More & Join Trial
Universal CAR-T Cells Targeting Multiple Myeloma PHASE1 The aim of this study is to assess the feasibility, safety and efficacy of ...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma PHASE1 This is a Phase 1, multicenter, open-label study o evaluate the safety and ...
Show More Location
Hematology Department of the First Affiliated Hospital of Zhejiang University
Learn More & Join Trial